Evidence map›Paper›PMID 32100710›Full record

ArticleMicrobial genomics2020

Comparison of Shiga toxin-encoding bacteriophages in highly pathogenic strains of Shiga toxin-producing

Daniel A Yara, David R Greig, David L Gally, Timothy J Dallman, Claire Jenkins

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 43 citations in OpenAlex.

  1. Mind the gap! TypingMicrobial genomics · 2026
    Article
  2. Predicting clinical outcome ofMicrobial genomics · 2025
    Article
  3. Increased detection of Shiga toxin-producingEpidemiology and infection · 2025
    Article
  4. Article
  5. Hybrid strains of enterotoxigenic/Shiga toxin-producingJournal of medical microbiology · 2025
    Article
  6. Article
  7. Article
  8. Diversity of Shiga toxin transducing phages inFrontiers in microbiology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Comparative Genomics ofMicroorganisms · 2022
    Article
  14. Article
  15. The epidemiology of Shiga toxin-producingEpidemiology and infection · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Daniel A YaraNorwich Medical School, University of East Anglia, Norwich, UK.
David R GreigNational Infection Service, Public Health England, London NW9 5EQ, UK.
David L GallyDivision of Infection and Immunity, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush EH25 9RG, UK.
Timothy J DallmanNational Infection Service, Public Health England, London NW9 5EQ, UK.
Claire JenkinsNational Infection Service, Public Health England, London NW9 5EQ, UK.
Roslin Institute · GBPublic Health England · GBUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Over the last 35 years in the UK, the burden of Shiga toxin-producing

Indexed as

BacteriophagesEscherichia coli O157PhylogenyShiga ToxinUnited KingdomShiga ToxinbacteriophageEscherichia coli O157:H7Shiga toxinwhole-genome sequencing

Identifiers

PMID32100710
PMCPMC7200060
OpenAlexW3007662372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.